Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003

Alan Johnson; Theresa Lamagni; Martin Wale; Sue Cavendish; Louise Bishop; Neelam Alhaddad; Marina Warner; David M. Livermore; Georgia Duckworth; Robert George

doi:10.1016/j.ijantimicag.2004.10.017

Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003

Alan Johnson^*, Theresa Lamagni, Martin Wale, Sue Cavendish, Louise Bishop, Neelam Alhaddad, Marina Warner, David M. Livermore, Georgia Duckworth, Robert George

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Susceptibility to moxifloxacin, penicillin and erythromycin was determined for 592 invasive Streptococcus pneumoniae collected from 20 English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) during 2003. Resistance to moxifloxacin, penicillin and erythromycin was observed in 0.8%, 5.4% and 13% of the isolates, respectively. These results show that the large majority of pneumococci were susceptible to moxifloxacin in 2003, the year when it was licensed for clinical use in the UK.

Original language	English
Pages (from-to)	539-541
Number of pages	3
Journal	International Journal of Antimicrobial Agents
Volume	25
Issue number	6
DOIs	https://doi.org/10.1016/j.ijantimicag.2004.10.017
Publication status	Published - Jun 2005

Bibliographical note

Funding Information:
EARSS is funded by the European Commission DG Sanco (Agreement S12.123794). The EARSS Collaborating Group for this study comprised Dr D. Brown (Addenbrooke's NHS Trust), Dr P. Cockcroft (Portsmouth Hospitals), Dr T. Collyns (St James's University Hospital–Teaching Hospitals NHS Trust, Leeds), Dr S. Cotterill, Dr M. Misra, Mr D. Dicks (Salisbury Health Care NHS Trust), Dr P. Godwin, Mrs G. McAndrew (Airedale General Hospital, Keighley), Dr A. Johnson, Dr M. Wilson, Mrs V.A. Cook (The County Hospital, Hereford Hospitals NHS Trust), Dr K. Loudon (Pilgrim Hospital, Boston), Dr A. Lowes, Mr A. Tuck (Southampton University Hospitals Trust), Dr N. Manek (The George Eliot Hospital NHS Trust), Dr P. Mannion (Countess of Chester NHS Trust), Dr J. Nash (East Kent NHS Trust), Dr P.B. Nielsen (Peterborough and Stamford Hospitals NHS Foundation Trust), Dr M. Osman (Barnsley District General NHS Trust), Dr J. Perry, Miss A. Nicholson (Freeman Hospital, Newcastle), Dr S. Pugh, Mr P. Cheetham, Miss J. Palfreyman (Department of Microbiology for University Hospital and City Hospital Nottingham), Dr R. Spencer, Ms G.M. Wilson (Health Protection Agency South West Regional Laboratory, Bristol), Dr J. Stockley (Worcestershire Royal Hospital), Dr A. Telfer Brunton, Mr J. Rogers (Royal Cornwall Hospitals Trust), Dr N. Weightman (Friarage Hospital, Northallerton), and Dr E. Youngs and Mr J. McCluskie (Lincoln County Hospital).

Keywords

Quinolones
Streptococcus pneumoniae
Susceptibility testing

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ijantimicag.2004.10.017

Cite this

Johnson, A., Lamagni, T., Wale, M., Cavendish, S., Bishop, L., Alhaddad, N., Warner, M., Livermore, D. M., Duckworth, G., & George, R. (2005). Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003. International Journal of Antimicrobial Agents, 25(6), 539-541. https://doi.org/10.1016/j.ijantimicag.2004.10.017

@article{12fe2e52add04fc9bd07851cd91f22cc,

title = "Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003",

abstract = "Susceptibility to moxifloxacin, penicillin and erythromycin was determined for 592 invasive Streptococcus pneumoniae collected from 20 English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) during 2003. Resistance to moxifloxacin, penicillin and erythromycin was observed in 0.8%, 5.4% and 13% of the isolates, respectively. These results show that the large majority of pneumococci were susceptible to moxifloxacin in 2003, the year when it was licensed for clinical use in the UK.",

keywords = "Quinolones, Streptococcus pneumoniae, Susceptibility testing",

author = "Alan Johnson and Theresa Lamagni and Martin Wale and Sue Cavendish and Louise Bishop and Neelam Alhaddad and Marina Warner and Livermore, {David M.} and Georgia Duckworth and Robert George",

note = "Funding Information: EARSS is funded by the European Commission DG Sanco (Agreement S12.123794). The EARSS Collaborating Group for this study comprised Dr D. Brown (Addenbrooke's NHS Trust), Dr P. Cockcroft (Portsmouth Hospitals), Dr T. Collyns (St James's University Hospital–Teaching Hospitals NHS Trust, Leeds), Dr S. Cotterill, Dr M. Misra, Mr D. Dicks (Salisbury Health Care NHS Trust), Dr P. Godwin, Mrs G. McAndrew (Airedale General Hospital, Keighley), Dr A. Johnson, Dr M. Wilson, Mrs V.A. Cook (The County Hospital, Hereford Hospitals NHS Trust), Dr K. Loudon (Pilgrim Hospital, Boston), Dr A. Lowes, Mr A. Tuck (Southampton University Hospitals Trust), Dr N. Manek (The George Eliot Hospital NHS Trust), Dr P. Mannion (Countess of Chester NHS Trust), Dr J. Nash (East Kent NHS Trust), Dr P.B. Nielsen (Peterborough and Stamford Hospitals NHS Foundation Trust), Dr M. Osman (Barnsley District General NHS Trust), Dr J. Perry, Miss A. Nicholson (Freeman Hospital, Newcastle), Dr S. Pugh, Mr P. Cheetham, Miss J. Palfreyman (Department of Microbiology for University Hospital and City Hospital Nottingham), Dr R. Spencer, Ms G.M. Wilson (Health Protection Agency South West Regional Laboratory, Bristol), Dr J. Stockley (Worcestershire Royal Hospital), Dr A. Telfer Brunton, Mr J. Rogers (Royal Cornwall Hospitals Trust), Dr N. Weightman (Friarage Hospital, Northallerton), and Dr E. Youngs and Mr J. McCluskie (Lincoln County Hospital). ",

year = "2005",

month = jun,

doi = "10.1016/j.ijantimicag.2004.10.017",

language = "English",

volume = "25",

pages = "539--541",

journal = "International Journal of Antimicrobial Agents",

issn = "0924-8579",

publisher = "Elsevier",

number = "6",

}

Johnson, A, Lamagni, T, Wale, M, Cavendish, S, Bishop, L, Alhaddad, N, Warner, M, Livermore, DM, Duckworth, G & George, R 2005, 'Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003', International Journal of Antimicrobial Agents, vol. 25, no. 6, pp. 539-541. https://doi.org/10.1016/j.ijantimicag.2004.10.017

Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003. / Johnson, Alan; Lamagni, Theresa; Wale, Martin et al.

In: International Journal of Antimicrobial Agents, Vol. 25, No. 6, 06.2005, p. 539-541.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003

AU - Johnson, Alan

AU - Lamagni, Theresa

AU - Wale, Martin

AU - Cavendish, Sue

AU - Bishop, Louise

AU - Alhaddad, Neelam

AU - Warner, Marina

AU - Livermore, David M.

AU - Duckworth, Georgia

AU - George, Robert

N1 - Funding Information: EARSS is funded by the European Commission DG Sanco (Agreement S12.123794). The EARSS Collaborating Group for this study comprised Dr D. Brown (Addenbrooke's NHS Trust), Dr P. Cockcroft (Portsmouth Hospitals), Dr T. Collyns (St James's University Hospital–Teaching Hospitals NHS Trust, Leeds), Dr S. Cotterill, Dr M. Misra, Mr D. Dicks (Salisbury Health Care NHS Trust), Dr P. Godwin, Mrs G. McAndrew (Airedale General Hospital, Keighley), Dr A. Johnson, Dr M. Wilson, Mrs V.A. Cook (The County Hospital, Hereford Hospitals NHS Trust), Dr K. Loudon (Pilgrim Hospital, Boston), Dr A. Lowes, Mr A. Tuck (Southampton University Hospitals Trust), Dr N. Manek (The George Eliot Hospital NHS Trust), Dr P. Mannion (Countess of Chester NHS Trust), Dr J. Nash (East Kent NHS Trust), Dr P.B. Nielsen (Peterborough and Stamford Hospitals NHS Foundation Trust), Dr M. Osman (Barnsley District General NHS Trust), Dr J. Perry, Miss A. Nicholson (Freeman Hospital, Newcastle), Dr S. Pugh, Mr P. Cheetham, Miss J. Palfreyman (Department of Microbiology for University Hospital and City Hospital Nottingham), Dr R. Spencer, Ms G.M. Wilson (Health Protection Agency South West Regional Laboratory, Bristol), Dr J. Stockley (Worcestershire Royal Hospital), Dr A. Telfer Brunton, Mr J. Rogers (Royal Cornwall Hospitals Trust), Dr N. Weightman (Friarage Hospital, Northallerton), and Dr E. Youngs and Mr J. McCluskie (Lincoln County Hospital).

PY - 2005/6

Y1 - 2005/6

N2 - Susceptibility to moxifloxacin, penicillin and erythromycin was determined for 592 invasive Streptococcus pneumoniae collected from 20 English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) during 2003. Resistance to moxifloxacin, penicillin and erythromycin was observed in 0.8%, 5.4% and 13% of the isolates, respectively. These results show that the large majority of pneumococci were susceptible to moxifloxacin in 2003, the year when it was licensed for clinical use in the UK.

AB - Susceptibility to moxifloxacin, penicillin and erythromycin was determined for 592 invasive Streptococcus pneumoniae collected from 20 English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) during 2003. Resistance to moxifloxacin, penicillin and erythromycin was observed in 0.8%, 5.4% and 13% of the isolates, respectively. These results show that the large majority of pneumococci were susceptible to moxifloxacin in 2003, the year when it was licensed for clinical use in the UK.

KW - Quinolones

KW - Streptococcus pneumoniae

KW - Susceptibility testing

UR - http://www.scopus.com/inward/record.url?scp=21144431966&partnerID=8YFLogxK

U2 - 10.1016/j.ijantimicag.2004.10.017

DO - 10.1016/j.ijantimicag.2004.10.017

M3 - Article

C2 - 15890501

AN - SCOPUS:21144431966

VL - 25

SP - 539

EP - 541

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 6

ER -

Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this